Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gamma Biologicals -- Ignore unavailable to you. Want to Upgrade?

To: A. Reader who wrote (40)	4/23/1998 6:01:00 PM
From: A. Reader	Read Replies (1) \| Respond to of 44

Gamma Biologicals Adds Donor Testing to ReACT Product Line FDA Approves Addition to Company's Licensed Reagent Red Cell Products HOUSTON--(BUSINESS WIRE)--April 23, 1998--Gamma Biologicals Inc. (Amex:GBL - news) has received FDA approval to market ReACT(tm) Screening Cell Pool. Screening of blood donors is a required routine test on all donations. Previously, the company's reagent red cell products for the ReACT were intended for patients who might receive blood transfusions. ''This newly approved product allows the technologist to screen large numbers of donors quickly, saving time and money. In addition to extending our ReACT product line, we have opened a new market for the estimated 12 million annual blood donations in the United States alone,'' said David E. Hatcher, Gamma's chairman, president and chief executive officer. ''Six additional tests using the patented ReACT adherence technology are under development,'' continued Hatcher, ''and our long-term plan is to expand the ReACT system to include a full line of testing products. These products under development will require FDA approval prior to marketing.'' biz.yahoo.com Gamma Bio gets FDA ok for blood screener HOUSTON, April 23 (Reuters) - Gamma Biologicals Inc. said Thursday it received approval from the Food and Drug Administration to market its ReACT Screening Cell Pool. The company said the blood donor screening product allows technologists to screen large numbers of donors quickly, saving time and money. Gamma also said that in addition to extending its ReACT product line, it opened a new market for the estimated 12 million annual blood donations in the United States. biz.yahoo.com